2026-04-11T09:44:07Z https://pub.unibl.org/oai

oai:pub.unibl.org:40236 2024-06-12T14:22:23Z

Academic Article text Comparing biosimilar SB2 with reference infiximab after 54 weeks of a double-bilind trail:Clinical, structural and safety results JS Smolen, JI Choe, Ненад Продановић, J Niebrizidovski, I Staikov, E Dokoupilova, A Baranauskaite, R Iatsishin, M Mekić, V Poravska, H Ciferska, K Jedrichovicz-Rosiak, A Zelinska, I Lee, IH Rho JS Smolen Unknown JI Choe Unknown Ненад Продановић Unknown J Niebrizidovski Unknown I Staikov Unknown E Dokoupilova Unknown A Baranauskaite Unknown R Iatsishin Unknown M Mekić Unknown V Poravska Unknown H Ciferska Unknown K Jedrichovicz-Rosiak Unknown A Zelinska Unknown I Lee Unknown IH Rho Unknown not applicable 2017 2017 2017 location unknown 40236 item oai:pub.unibl.org:40236